Company profile for Brammer Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Brammer Bio is a contract development and manufacturing organization (CDMO) serving companies seeking to develop and commercialize gene therapies. ​Brammer is an experienced viral vector CDMO supporting gene therapies, and is focused on process and analytical development, and clinical and commercial supply. With more than a decade of experience, our over 500-strong, highly skilled team has managed over 100 client projects de...
Brammer Bio is a contract development and manufacturing organization (CDMO) serving companies seeking to develop and commercialize gene therapies. ​Brammer is an experienced viral vector CDMO supporting gene therapies, and is focused on process and analytical development, and clinical and commercial supply. With more than a decade of experience, our over 500-strong, highly skilled team has managed over 100 client projects delivering first-in-human clinical materials to accelerate our client’s products from the laboratory to patients in need. We work in close collaboration with each client’s team to deliver successful programs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
250 Binney Street Cambridge, MA 02142
Telephone
Telephone
+1 386 418 8199
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
Thermo Fisher to invest $180M in new gene therapy plant
Thermo Fisher to invest $180M in new gene therapy plant

13 May 2020

// Kristin Jensen BIOPHARMADIVE

https://www.biopharmadive.com/news/thermo-fisher-gene-therapy-viral-vector-plant/577872/

Kristin Jensen BIOPHARMADIVE
13 May 2020

https://www.fiercepharma.com/manufacturing/new-cdmo-backed-by-private-equity-player-to-make-biologics

Eric Palmer  FIERCE PHARMA
18 Oct 2019

https://endpts.com/pfizer-is-making-a-500m-statement-today-heres-how-you-become-a-lead-player-in-the-booming-gene-therapy-sector/

John Carroll ENDPTS
21 Aug 2019

http://www.pharmafile.com/news/526292/brammer-bio-set-new-plant-norton-massachusetts

PHARMAFILE
12 Aug 2019

http://www.pharmafile.com/news/526292/brammer-bio-set-new-plant-norton-massachusetts

PHARMAFILE
12 Aug 2019

https://www.contractpharma.com/contents/view_breaking-news/2019-07-01/amicus-brammer-bio-enter-gene-therapy-devt-and-mfg-collaboration/

CONTRACT PHARMA
02 Jul 2019

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty